Increased plasma levels of IL-6 and TNF-α have now been demonstrated in NAFLD and NASH patients, and increased production of TNF-α and IL-6 by peripheral blood mononuclear cells from NASH patients (117). Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.